Results 61 to 70 of about 15,000 (182)

The stages in standardizing erythropoietin preparations

Биопрепараты: Профилактика, диагностика, лечение, 2018
Preparations of recombinant human erythropoietin (rhEPO) are included in the list of vital and essential drugs for medical use. When evaluating the quality of EPO preparations during the manufacturing process, under the state marketing authorization and ...
A. K. Yakovlev, L. A. Gayderova, N. A. Alpatova, T. N. Lobanova, T. A. Batuashvili, L. V. Simutenko, E. L. Postnova, E. I. Yurchikova   +7 more
doaj  

Protective Activity of Erythropoyetine in the Cognition of Patients with Parkinson’s Disease

Behavioral Sciences, 2018
Introduction: Treatment strategies in Parkinson’s disease (PD) can improve a patient’s quality of life but cannot stop the progression of PD.
Ivonne Pedroso, Marité Garcia, Enrique Casabona, Lilia Morales, Maria Luisa Bringas, Leslie Pérez, Teresita Rodríguez, Ileana Sosa, Yordanka Ricardo, Arnoldo Padrón, Daniel Amaro   +10 more
doaj   +1 more source

Koreksi Anemia dengan Terapi Recombinant Human Erythropoietin pada Anak dengan Penyakit Ginjal Kronis

Sari Pediatri
Latar belakang. Anemia merupakan salah satu komplikasi tersering pada penyakit ginjal kronis serta dapat meningkatkan risiko mortalitas hingga 52%. Terapi anemia dengan recombinant human erythropoietin mampu meningkatkan kadar hemoglobin dengan sifat ...
Savira Savira, Kristia Hermawan, Pudjo Hagung Widjajanto   +2 more
doaj   +1 more source

Use of Recombinant Human Erythropoietin in Renal Anemia in Children

Bangabandhu Sheikh Mujib Medical University Journal, 2009
Erythropoietin is a hormone highly effective as like as natural erythropoietin to maintain target hemoglobin and hematocrit level in renal anemia. Its advantage over blood transfusion has been proved by improving the quality of life and decreasing ...
Habibur Rahman, Salma Jahan, Afroza Begum, Golam Muinuddin, MM Hossain   +4 more
doaj   +1 more source

COMPARISON OF COLORIMETRIC AND CHEMILUMINESCENT ELISA TESTS FOR DETECTION OF IgG ANTIBODIES TO HUMAN EPO IN THE SERA OF EXPERIMENTAL ANIMALS

Медицинская иммунология, 2018
Production of antibodies to erythropoietin-stimulating drugs is an important problem of therapy with recombinant human erythropoietin (EPO). It leads to changes in the pharmacokinetic profile and decreased therapeutic efficiency. Upon long-term treatment
A. M. Kudryashova, N. A. Mikhailova, O. V. Borisova   +2 more
doaj   +1 more source

Recombinant Human Erythropoietin and Peritoneal Dialysis [PDF]

The International Journal of Artificial Organs, 1990
DIGENIS, GE, YATZIDIS, H
openaire   +3 more sources

Erythropoietin use and abuse

Indian Journal of Endocrinology and Metabolism, 2012
Recombinant human erythropoietin (rhEPO) is arguably the most successful therapeutic application of recombinant DNA technology till date. It was isolated in 1977 and the gene decoded in 1985.
M Joseph John, Vineeth Jaison, Kunal Jain, Naveen Kakkar, Jubbin J Jacob   +4 more
doaj   +1 more source

Recombinant human erythropoietin protects against immature brain damage induced by hypoxic/ischemia insult. [PDF]

Neuroreport, 2023
Sun Z, Song J, Song Q, Li L, Tian X, Wang L.   +5 more
europepmc   +1 more source

Author Correction: Effect of recombinant human erythropoietin combined with iron sucrose on postoperative hemoglobin in patients undergoing artificial joint replacement. [PDF]

Sci Rep, 2023
Yu W, Liu C, Bi Z.
europepmc   +1 more source

Effect of recombinant human erythropoietin combined with iron sucrose on postoperative hemoglobin in patients undergoing artificial joint replacement. [PDF]

Sci Rep, 2023
Yu W, Liu C, Bi Z.
europepmc   +1 more source